Caris Life Sciences IPO: Unlocking AI-Driven Biotech Growth
Explore how Caris Life Sciences’ AI-powered biotech IPO reshapes precision medicine investing, signaling fresh momentum in 2025’s biotech market with a $7.6 billion valuation and innovative cancer diagnostics.